Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ofogh Tolid Darou Pars (OTDP), also known as Ofogh Darou, is a private Iranian pharmaceutical and nutritional supplement manufacturing company founded in 2016. Headquartered in Tehran with a state-of-the-art manufacturing facility in the Kaveh Industrial Town in Saveh, the company produces a wide range of pharmaceuticals, nutraceuticals, and dietary supplements under EU GMP standards. OTDP collaborates with several international partners, manufacturing products under license from brands such as Next Supplement, My Nutrition, and Bioformula. Its product portfolio includes treatments for joint health, anemia, respiratory conditions, allergies, and various vitamin and mineral supplements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ofogh Daru.